Rover Diagnostics
PrivateLast Round
Grant
Jul 15, 2024
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Rover Diagnostics is a life sciences company that develops portable, point-of-care PCR diagnostic devices for the detection of infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Precision Medicine, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rover Diagnostics Comparables
Compare Rover Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nanopath | 83% | |
| Genomadix Inc. | 82% | |
| FluxErgy | 82% |
Rover Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 15, 2024 | ||||
| Grant | Oct 22, 2020 |
Rover Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Columbia Technology Ventures | Seed |
| Harlem Biospace | Seed |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 25, 2026
Grew 23% QoQ, from 13 to 16 employees.
- Apr 25, 2026
Grew 21% QoQ, from 14 to 17 employees.
Rover Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access